Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
212.00    5.00 (2.42%)
Bid:
211.00
Ask:
212.00
Spread: 1.00 (0.474%)
Market Cap: £565.01m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Scrip Dividend Reference Price

28 Sep 2023 12:00

RNS Number : 0273O
Costain Group PLC
28 September 2023
 

 

 

Costain Group PLC (the 'Company')

28 September 2023

 

Scrip Dividend Reference Price

 

The Company announces that the Scrip Dividend Reference Price for the fully paid shares in the Company to be issued to shareholders who elect to receive the scrip dividend alternative for the interim dividend for the year ending 31 December 2023 is 56.64 pence per ordinary share of 50 pence each. 

The Scrip Dividend Reference Price has been calculated as the average value of the middle market quotations for the Company's ordinary shares as derived from the Daily Official List of the London Stock Exchange for the five consecutive dealing days commencing on the ex-dividend date. The Company's ordinary shares were marked ex-dividend on 21 September 2023.

Further Information:

Shareholders wishing to receive the scrip dividend in respect of the interim dividend for the year ending 31 December 2023 and who have not already submitted a mandate form should return a mandate form to the Registrar, Equiniti, Share Dividend Team, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA by 6 October 2023.

For more information regarding the scrip dividend including the terms, and to download the mandate form, see Costain scrip

If you have already completed a valid scrip dividend mandate form, it will remain valid until you cancel your election and you need not return any documentation to receive this scrip dividend.

The interim dividend for the year ending 31 December 2023, including the scrip dividend, will be paid on 27 October 2023 (the dividend payment date) to the ordinary shareholders of the Company on the register at close of business on 22 September 2023 (the record date).

For further information, please contact Equiniti on +44 (0)371 384 2268*.

 

Enquiries

 

Investors and analysts

Paul Sharma, Costain

paul.sharma@costain.com

+44 (0) 7867 501188

 

Financial media - Headland

costain@headlandconsultancy.com

Andy Rivett-Carnac

+44 (0) 7968 997 365

Charlie Twigg

+44 (0) 7946 494 568

 

 

* Please use the country code when calling from outside the UK. Lines are open from 08:30 to 17:30 (UK time), Monday to Friday (excluding public holidays in England and Wales).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVKZGZLGRRGFZM
Date   Source Headline
7th Oct 202012:10 pmRNSLong Term Incentive Plan Awards
5th Oct 20207:00 amRNSDirectorate Change
24th Sep 20209:20 amRNSHolding(s) in Company
14th Sep 20207:00 amRNSResults for the half year ended 30 June 2020
9th Sep 20201:08 pmRNSHolding(s) in Company
3rd Sep 20207:00 amRNSUpdate on the A465 contract
17th Aug 20207:00 amRNSTrading Update and Revised Date of Half Year
7th Aug 202012:07 pmRNSSecond Price Monitoring Extn
7th Aug 202012:02 pmRNSPrice Monitoring Extension
5th Aug 20202:09 pmRNSHolding(s) in Company
31st Jul 20207:05 amRNSBoard Notification – External Directorship
14th Jul 202010:30 amRNSCostain awarded Cadent contract
1st Jul 20209:15 amRNSBlock listing Interim Return
29th Jun 20207:00 amRNSPeterborough and Huntington Compressor Stations
19th Jun 202011:30 amRNSResult of AGM
19th Jun 20207:00 amRNSAGM trading update
15th Jun 20204:10 pmRNSDirector/PDMR Shareholding
10th Jun 202012:45 pmRNSDirector/PDMR Shareholding
9th Jun 20207:05 amRNSBoard Notification – External Directorship
8th Jun 20207:00 amRNSCostain Appointed onto Strategic Pipeline Alliance
4th Jun 20204:36 pmRNSHolding(s) in Company - Replacement
3rd Jun 20203:35 pmRNSHolding(s) in Company
2nd Jun 20203:38 pmRNSHolding(s) in Company
2nd Jun 20203:31 pmRNSHolding(s) in Company
2nd Jun 202012:07 pmRNSHolding(s) in Company
29th May 202012:00 pmRNSAppointment of non-executive director
29th May 202011:34 amRNSDirector/PDMR Shareholding
28th May 20205:49 pmRNSHolding(s) in Company
28th May 20207:00 amRNSResults of Capital Raising and General Meeting
18th May 20209:05 amRNSNotice of 2020 Annual General Meeting
7th May 20201:20 pmRNSPublication of Prospectus
7th May 202010:42 amRNSCompletion of bookbuild
7th May 20207:00 amRNSProposed £100 million Capital Raising
27th Apr 20207:00 amRNSSmart Motorway Programme Alliance
15th Apr 20207:05 amRNSUpdate on Contracts
2nd Apr 20209:38 amRNSAnnual Report and Accounts
31st Mar 20207:00 amRNSUpdate on COVID-19
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn
25th Mar 20204:35 pmRNSPrice Monitoring Extension
25th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20203:32 pmRNSHolding(s) in Company
16th Mar 20204:43 pmRNSSecond Price Monitoring Extn
16th Mar 20204:37 pmRNSPrice Monitoring Extension
11th Mar 20207:00 amRNSFully Underwritten Capital Raising of up to £100m
11th Mar 20207:00 amRNSFinal Results
13th Feb 20203:44 pmRNSHolding(s) in Company
6th Feb 20207:05 amRNSDirectorate Change
2nd Jan 202010:00 amRNSBlock listing Six Monthly Return
12th Dec 20197:00 amRNSUpdate on the A465 contract and trading
11th Dec 20191:32 pmRNSCompletion of the Disposal of Alcaidesa Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.